Organotin (IV) Dithiocarbamate Compounds as Anticancer Agents: A Review of Syntheses and Cytotoxicity Studies

Organotin (IV) dithiocarbamate has recently received attention as a therapeutic agent among organotin (IV) compounds. The individual properties of the organotin (IV) and dithiocarbamate moieties in the hybrid complex form a synergy of action that stimulates increased biological activity. Organotin (IV) components have been shown to play a crucial role in cytotoxicity. The biological effects of organotin compounds are believed to be influenced by the number of Sn-C bonds and the number and nature of alkyl or aryl substituents within the organotin structure. Ligands target and react with molecules while preventing unwanted changes in the biomolecules. Organotin (IV) dithiocarbamate compounds have also been shown to have a broad range of cellular, biochemical, and molecular effects, with their toxicity largely determined by their structure. Continuing the investigation of the cytotoxicity of organotin (IV) dithiocarbamates, this mini-review delves into the appropriate method for synthesis and discusses the elemental and spectroscopic analyses and potential cytotoxic effects of these compounds from articles published since 2010.

Automated summary

Organotin (IV) dithiocarbamate has gained attention as a therapeutic agent due to its unique properties and increased biological activity. The cytotoxicity of organotin (IV) compounds is influenced by the number of Sn-C bonds and the nature of substituents within the structure. Ligands target and react with molecules to prevent unwanted changes in biomolecules. Organotin (IV) dithiocarbamate compounds have various effects at the cellular, biochemical, and molecular levels, and their toxicity depends on their structure. This mini-review focuses on the synthesis, elemental and spectroscopic analyses, and potential cytotoxic effects of these compounds.